


Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate

Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections

Domain Therapeutics appoints Xavier Leroy as chief technology officer

GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer

Nosopharm and Evotec enter into collaboration toaccelerate development of novel antibiotics

Oncovita signs exclusive licensing agreement with Institut Pasteur

Domain Therapeutics strengthens its scientific advisory board with leading GPCR and disease experts

Axovant and Yposkesi sign strategic gene therapy development and manufacturing partnership
